Raymond James & Associates’s UiPath PATH Stock Holding History
Bought
Maintained
Sold
Other funds holding PATH
AIM
NAMA
SM
AI
Raymond James & Associates's PATH Position: Q3 2024 in Review
Raymond James & Associates increased its UiPath (PATH) stake by 4.3% in Q3 2024, buying an estimated $120K and bringing the position to 240,145 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1955.
Raymond James & Associates first reported a position in PATH in Q2 2021 and has held it in 14 quarters since. The position peaked at $9.38M in Q4 2021. 420 funds tracked by Wall St. Rank hold PATH as of Q3 2024.
- Raymond James & Associates held 240,145 shares of UiPath worth $3.07M as of Q3 2024.
- Raymond James & Associates bought 9,814 UiPath shares in Q3 2024, an estimated $120K.
- UiPath made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1955 holding.
- Raymond James & Associates first reported a position in UiPath in Q2 2021 and has held it in 14 quarters since.
- Raymond James & Associates's UiPath position peaked at $9.38M in Q4 2021.
- 420 funds tracked by Wall St. Rank held UiPath as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.